Compounds > oxymetholone
Page last updated: 2024-08-21

oxymetholone and warfarin

oxymetholone has been researched along with warfarin in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19905 (62.50)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (37.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Abe, T; Nagasawa, T; Nakazawa, M; Ninomiya, H; Shibuya, A; Yoda, Y2
Ellis, JE; Hawkins, JB; Moore-Robinson, M; Robinson, BH1
De Oya, JC; Del Río, A; Noya, M; Villanueva, A1
Curtis, JR; Edwards, MS1

Reviews

1 review(s) available for oxymetholone and warfarin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

7 other study(ies) available for oxymetholone and warfarin

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Oxymetholone therapy in patients with familial antithrombin III deficiency.
    Thrombosis and haemostasis, 1988, Dec-22, Volume: 60, Issue:3

    Topics: Adolescent; Antithrombin III; Antithrombin III Deficiency; Blood Coagulation Tests; Drug Therapy, Combination; Female; Humans; Japan; Male; Middle Aged; Oxymetholone; Thromboembolism; Warfarin

1988
[Congenital antithrombin III (ATIII) deficiency with thrombosis of superior sagittal sinus and of inferior vena cava].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1987, Volume: 28, Issue:11

    Topics: Adolescent; Antithrombin III Deficiency; Blood Coagulation Disorders; Drug Therapy, Combination; Dura Mater; Humans; Male; Oxymetholone; Sinus Thrombosis, Intracranial; Thrombosis; Vena Cava, Inferior; Warfarin

1987
Decreased anticoagulant tolerance with oxymetholone.
    Lancet (London, England), 1971, Jun-26, Volume: 1, Issue:7713

    Topics: Anemia; Hemorrhage; Humans; Oxymetholone; Warfarin

1971
Decreased anticoagulant tolerance with oxymetholone in paroxysmal nocturnal haemoglobinuria.
    Lancet (London, England), 1971, Jul-31, Volume: 2, Issue:7718

    Topics: Adult; Anticoagulants; Drug Tolerance; Hemoglobinuria, Paroxysmal; Humans; Male; Oxymetholone; Phenindione; Warfarin

1971
Decreased anticoagulant tolerance with oxymetholone.
    Lancet (London, England), 1971, Jul-24, Volume: 2, Issue:7717

    Topics: Alanine Transaminase; Anticoagulants; Aspartate Aminotransferases; Drug Tolerance; Humans; Oxymetholone; Renal Dialysis; Time Factors; Warfarin

1971